We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Multiple Vessel Recanalization Results in High Limb Salvage Rate

By HospiMedica International staff writers
Posted on 06 Dec 2010
A new surgical approach, which involves arterial and venous recanalization prior to addressing diabetic ulcers in patients with critical limb ischemia, has reported a salvage rate better than 97%. More...


Researchers from the Policlinico Abano Terme (Vicenza, Italy) reported the results of multiple-vessel recanalization technique in 1,019 diabetic patients with critical limb ischemia, treated between January 2007 and September 2010. The surgical technique involves a pedal-plantar loop technique, which uses two wires to improve and maintain outflow in the wound-related arteries, and to rescue patients who have failed on other treatments. The patients were followed for a mean of 9.7 years.

The results showed that limb salvage was 97.2%, and ambulatory function was restored in 78% of patients. Unplanned major amputations occurred in 2.5% of patients, and planned minor amputations (below the ankle) were performed in 32.3%. In all, 319 patients were completely revascularized and 207 were partially revascularized. The complete or partial success rate was 51.6%, with the failures to revascularize attributed to a number of technical limitations of the technique, including severe calcifications and anatomic variations that made treatment challenging. The study was presented at the 37th annual VEITH Symposium, held during November 2010 in New York (NY, USA).

"The old concept was to recanalize one vessel. Now we know that is not enough. We need to revascularize at least two or three vessels and, when possible, the foot arteries for inflow to the limb and outflow to the foot,” said lead author and study presenter Marco Manzi, MD. "You need to identify the wound-related artery and treat that vessel first. This will give you a shorter recovery time and is the best surgical treatment.”

Related Links:
Policlinico Abano Terme


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.